Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Helix BioPharma Corp. Announces Selection of CEO; Plans to Voluntarily Delist From NYSE MKT
Helix BioPharma Corp. Announces Selection of CEO; Plans to Voluntarily Delist From NYSE MKT
Helix BioPharma Corp. Announces Selection of CEO; Plans to Voluntarily Delist From NYSE MKT
Submitted by
moderatorj
on June 25, 2012 - 11:24pm
Source:
Yahoo/MarketWire
News Tags:
Helix BioPharma
CEO
Headline:
Helix BioPharma Corp. Announces Selection of CEO; Plans to Voluntarily Delist From NYSE MKT
Do Not Allow Advertisers to Use My Personal information
